The impact of polyphenols on chondrocyte growth and survival: a preliminary report

References

• Menendez JA, Joven J, Aragones G, Barrajon-Catalan E, Beltran-Debon R, Borras-Linares I, etal. Xenohormetic and anti-aging activity of secoiridoid polyphenols present in extra virgin olive oil: a new family of gerosuppressant agents. Cell Cycle. 2013; 12: 555–78.
   PubMed Web of Science ®Google Scholar
• Joven J, Rull A, Rodriguez-Gallego E, Camps J, Riera-Borrull M, Hernandez-Aguilera A, etal. Multifunctional targets of dietary polyphenols in disease: a case for the chemokine network and energy metabolism. Food Chem Toxicol. 2013; 51: 267–79.
   Web of Science ®Google Scholar
• Joven J, Espinel E, Rull A, Aragones G, Rodriguez-Gallego E, Camps J, etal. Plant-derived polyphenols regulate expression of miRNA paralogs miR-103/107 and miR-122 and prevent diet-induced fatty liver disease in hyperlipidemic mice. Biochim Biophys Acta. 2012; 1820: 894–9.
   PubMed Web of Science ®Google Scholar
• Joven J, Micol V, Segura-Carretero A, Alonso-Villaverde C, Menendez JA, Platform BFC. Polyphenols and the modulation of gene expression pathways: can we eat our way out of the danger of chronic disease?. Crit Rev Food Sci Nutr. 2014; 54: 985–1001.
   PubMed Web of Science ®Google Scholar
• Takei Y, Minamizaki T, Yoshiko Y. Functional diversity of fibroblast growth factors in bone formation. Int J Endocrinol. 2015; 2015: 729352.
   PubMed Web of Science ®Google Scholar
• Lelliott CJ, Ahnmark A, Admyre T, Ahlstedt I, Irving L, Keyes F, etal. Monoclonal antibody targeting of fibroblast growth factor receptor 1c ameliorates obesity and glucose intolerance via central mechanisms. PLoS One. 2014; 9: e112109.
   PubMed Web of Science ®Google Scholar
• Abe M, Naski MC. Regulation of sprouty expression by PLC-gamma and calcium-dependent signals. Biochem Biophys Res Comm. 2004; 323: 1040–7.
   Web of Science ®Google Scholar
• Hart KC, Robertson SC, Donoghue DJ. Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, stat activation, and phosphatidylinositol 3-kinase activation. Mol Biol Cell. 2001; 12: 931–42.
   PubMed Web of Science ®Google Scholar
• d'Anglemont de Tassigny A, Berdeaux A, Souktani R, Henry P, Ghaleh B. The volume-sensitive chloride channel inhibitors prevent both contractile dysfunction and apoptosis induced by doxorubicin through PI3kinase, Akt and Erk 1/2. Eur J Heart Fail. 2008; 10: 39–46.
   Web of Science ®Google Scholar
• Cross MJ, Lu L, Magnusson P, Nyqvist D, Holmqvist K, Welsh M, etal. The Shb adaptor protein binds to tyrosine 766 in the FGFR-1 and regulates the Ras/MEK/MAPK pathway via FRS2 phosphorylation in endothelial cells. Mol Biol Cell. 2002; 13: 2881–93.
   PubMed Web of Science ®Google Scholar
• Daleprane JB, Freitas Vda S, Pacheco A, Rudnicki M, Faine LA, Dorr FA, etal. Anti-atherogenic and anti-angiogenic activities of polyphenols from propolis. J Nutr Biochem. 2012; 23: 557–66.
   Web of Science ®Google Scholar
• Sarruf DA, Thaler JP, Morton GJ, German J, Fischer JD, Ogimoto K, etal. Fibroblast growth factor 21 action in the brain increases energy expenditure and insulin sensitivity in obese rats. Diabetes. 2010; 59: 1817–24.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Ngwa JS, van Rooij FJ, Zillikens MC, Wojczynski MK, Frazier-Wood AC, etal. Genome-wide meta-analysis of observational studies shows common genetic variants associated with macronutrient intake. Am J Clin Nutr. 2013; 97: 1395–402.
   PubMed Web of Science ®Google Scholar
• Wu J, Wei T, Tang Q, Weng B, Li W, Jiang X, etal. Discovery and anti-cancer evaluation of two novel non-ATP-competitive FGFR1 inhibitors in non-small-cell lung cancer. BMC Cancer. 2015; 15: 276.
   PubMed Web of Science ®Google Scholar
• Kelleher FC, O'Sullivan H, Smyth E, McDermott R, Viterbo A. Fibroblast growth factor receptors, developmental corruption and malignant disease. Carcinogenesis. 2013; 34: 2198–205.
   PubMed Web of Science ®Google Scholar
• Lemmon MA, Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell. 2010; 141: 1117–34.
   PubMed Web of Science ®Google Scholar
• Song JY, Kim CS, Lee JH, Jang SJ, Lee SW, Hwang JJ, etal. Dual inhibition of MEK1/2 and EGFR synergistically induces caspase-3-dependent apoptosis in EGFR inhibitor-resistant lung cancer cells via BIM upregulation. Invest New Drugs. 2013; 31: 1458–65.
   PubMed Web of Science ®Google Scholar
• Raj T, Kanellakis P, Pomilio G, Jennings G, Bobik A, Agrotis A. Inhibition of fibroblast growth factor receptor signaling attenuates atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol. 2006; 26: 1845–51.
   PubMed Web of Science ®Google Scholar
• Bohensky J, Terkhorn SP, Freeman TA, Adams CS, Garcia JA, Shapiro IM, etal. Regulation of autophagy in human and murine cartilage hypoxia-inducible factor 2 suppresses chondrocyte autophagy. Arthritis Rheum. 2009; 60: 1406–15.
   PubMed Web of Science ®Google Scholar
• Lazarus JE, Hegde A, Andrade AC, Nilsson O, Baron J. Fibroblast growth factor expression in the postnatal growth plate. Bone. 2007; 40: 577–86.
   PubMed Web of Science ®Google Scholar
• Al Hussain TO, Akhtar M. Molecular basis of urinary bladder cancer. Adv Anat Pathol. 2013; 20: 53–60.
   PubMed Web of Science ®Google Scholar
• Blomberg M, Jeppesen EM, Skovby F, Benfeldt E. FGFR3 mutations and the skin: report of a patient with a FGFR3 gene mutation, acanthosis nigricans, hypochondroplasia and hyperinsulinemia and review of the literature. Dermatology. 2010; 220: 297–305.
   PubMed Web of Science ®Google Scholar
• Baujat G, Legeai-Mallet L, Finidori G, Cormier-Daire V, Le Merrer M. Achondroplasia. Best Pract Res Clin Rheumatol. 2008; 22: 3–18.
   PubMed Web of Science ®Google Scholar
• Foldynova-Trantirkova S, Wilcox WR, Krejci P. Sixteen years and counting: the current understanding of fibroblast growth factor receptor 3 (FGFR3) signaling in skeletal dysplasias. Hum Mutat. 2012; 33: 29–41.
   PubMed Web of Science ®Google Scholar
• Leong DJ, Choudhury M, Hirsh DM, Hardin JA, Cobelli NJ, Sun HB. Nutraceuticals: potential for chondroprotection and molecular targeting of osteoarthritis. Int J Mol Sci. 2013; 14: 23063–85.
   Web of Science ®Google Scholar
• Guzman-Aranguez A, Irazu M, Yayon A, Pintor J. Effect of diadenosine polyphosphates in achondroplasic chondrocytes: inhibitory effect of Ap(4)A on FGF9 induced MAPK cascade. Biochem Pharmacol. 2007; 74: 448–56.
   Web of Science ®Google Scholar
• Guzman-Aranguez A, Irazu M, Yayon A, Pintor J. P2Y receptors activated by diadenosine polyphosphates reestablish Ca2+ transients in achondroplasic chondrocytes. Bone. 2008; 42: 516–23.
   Web of Science ®Google Scholar
• Huete F, Guzman-Aranguez A, Ortin J, Hoyle CHV, Pintor J. Effects of diadenosine tetraphosphate on FGF9-induced chloride flux changes in achondroplastic chondrocytes. Purinergic Signal. 2011; 7: 243–9.
   PubMed Web of Science ®Google Scholar
• Garcia S, Dirat B, Tognacci T, Rochet N, Mouska X, Bonnafous S, etal. Postnatal soluble FGFR3 therapy rescues achondroplasia symptoms and restores bone growth in mice. Sci Transl Med. 2013; 5: 203ra124.
   Web of Science ®Google Scholar
• Oliveras-Ferraros C, Cufi S, Queralt B, Vazquez-Martin A, Martin-Castillo B, de Llorens R, etal. Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells. Br J Cancer. 2012; 106: 1406–14.
   Web of Science ®Google Scholar
• Herranz-Lopez M, Fernandez-Arroyo S, Perez-Sanchez A, Barrajon-Catalan E, Beltran-Debon R, Abel Menendez J, etal. Synergism of plant-derived polyphenols in adipogenesis: perspectives and implications. Phytomedicine. 2012; 19: 253–61.
   PubMed Web of Science ®Google Scholar
• Monsonego-Ornan E, Adar R, Feferman T, Segev O, Yayon A. The transmembrane mutation G380R in fibroblast growth factor receptor 3 uncouples ligand-mediated receptor activation from down-regulation. Mol Cell Biol. 2000; 20: 516–22.
   PubMed Web of Science ®Google Scholar
• Monsonego-Ornan E, Adar R, Rom E, Yayon A. FGF receptors ubiquitylation: dependence on tyrosine kinase activity and role in downregulation. FEBS Lett. 2002; 528: 83–9.
   PubMed Web of Science ®Google Scholar
• Tian M, Duan Y, Duan X. Chloride channels regulate chondrogenesis in chicken mandibular mesenchymal cells. Arch Oral Biol. 2010; 55: 938–45.
   PubMed Web of Science ®Google Scholar
• Koncz C, Daugirdas JT. Use of MQAE for measurement of intracellular [Cl-] in cultured aortic smooth muscle cells. Am J Physiol. 1994; 267: H2114–23.
   Google Scholar
• Marandi N, Konnerth A, Garaschuk O. Two-photon chloride imaging in neurons of brain slices. Pflugers Arch. 2002; 445: 357–65.
   Web of Science ®Google Scholar
• Yoon YM, Kim SJ, Oh CD, Ju JW, Song WK, Yoo YJ, etal. Maintenance of differentiated phenotype of articular chondrocytes by protein kinase C and extracellular signal-regulated protein kinase. J Biol Chem. 2002; 277: 8412–20.
   PubMed Web of Science ®Google Scholar
• Kim SH, Turnbull J, Guimond S. Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. J Endocrinol. 2011; 209: 139–51.
   PubMed Web of Science ®Google Scholar
• Lunstrum GP, Keene DR, Weksler NB, Cho YJ, Cornwall M, Horton WA. Chondrocyte differentiation in a rat mesenchymal cell line. J Histochem Cytochem. 1999; 47: 1–6.
   PubMed Web of Science ®Google Scholar
• Rousseau F, Bonaventure J, Legeai-Mallet L, Pelet A, Rozet JM, Maroteaux P, etal. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature. 1994; 371: 252–4.
   PubMed Web of Science ®Google Scholar
• Warman ML, Cormier-Daire V, Hall C, Krakow D, Lachman R, LeMerrer M, etal. Nosology and classification of genetic skeletal disorders: 2010 revision. Am J Med Genet A. 2011; 155a: 943–68.
   PubMed Web of Science ®Google Scholar
• Lewis R, Asplin KE, Bruce G, Dart C, Mobasheri A, Barrett-Jolley R. The role of the membrane potential in chondrocyte volume regulation. J Cell Physiol. 2011; 226: 2979–86.
   PubMed Web of Science ®Google Scholar
• Britten CD. PI3K and MEK inhibitor combinations: examining the evidence in selected tumor types. Cancer Chemother Pharmacol. 2013; 71: 1395–409.
   PubMed Web of Science ®Google Scholar
• Dent P. ERK plays the baddie (again). Cancer Biol Ther. 2013; 14: 997–8.
   PubMed Web of Science ®Google Scholar
• Dhawan V, Mahajan N, Bhat OM, Bahl A, Sharma I. ERK signaling is involved in inflammation and vascular remodeling process in premature coronary artery disease. Atheroscler Suppl. 2011; 12: 88.
   Web of Science ®Google Scholar
• Johnson GL, Nakamura K. The c-jun kinase/stress-activated pathway: regulation, function and role in human disease. Biochim Biophys Acta. 2007; 1773: 1341–8.
   PubMed Web of Science ®Google Scholar
• Lesch ME, Huber C, Jordan HJ, Schrier D, Thiel M, Flory C. The effect of inhibiting the MEK-ERK MAPK pathway on inflammation and articular cartilage integrity in a rat model of collagen-induced arthritis. FASEB J. 2001; 15: A1061.
   Google Scholar
• Saini KS, Loi S, de Azambuja E, Metzger-Filho O, Saini ML, Ignatiadis M, etal. Targeting the PI3K/AKT/mTOR and Raf/MEK/ERK pathways in the treatment of breast cancer. Cancer Treat Rev. 2013; 39: 935–46.
   PubMed Web of Science ®Google Scholar
• Ajiboye TO, Salawu NA, Yakubu MT, Oladiji AT, Akanji MA, Okogun JI. Antioxidant and drug detoxification potentials of Hibiscus sabdariffa anthocyanin extract. Drug Chem Toxicol. 2011; 34: 109–15.
   PubMed Web of Science ®Google Scholar
• Beltran-Debon R, Alonso-Villaverde C, Aragones G, Rodriguez-Medina I, Rull A, Micol V, etal. The aqueous extract of Hibiscus sabdariffa calices modulates the production of monocyte chemoattractant protein-1 in humans. Phytomedicine. 2010; 17: 186–91.
   PubMed Web of Science ®Google Scholar
• Fernandez-Arroyo S, Camps J, Menendez JA, Joven J. Managing hypertension by polyphenols. Planta Med. 2015; 81: 624–9.
   Web of Science ®Google Scholar
• Lin HH, Chen JH, Wang CJ. Chemopreventive properties and molecular mechanisms of the bioactive compounds in Hibiscus sabdariffa Linne. Curr Med Chem. 2011; 18: 1245–54.
   PubMed Web of Science ®Google Scholar
• Ubani CS, Joshua PE, Anieke UC. Effects of aqueous extract of Hibiscus sabdariffa L. calyces on liver marker enzymes of phenobarbitone-induced adult wistar albino rats. J Chem Pharm Res. 2011; 3: 528–37.
   Google Scholar
• Yang MY, Peng CH, Chan KC, Yang YS, Huang CN, Wang CJ. The hypolipidemic effect of Hibiscus sabdariffa polyphenols via inhibiting lipogenesis and promoting hepatic lipid clearance. J Agric Food Chem. 2010; 58: 850–9.
   PubMed Web of Science ®Google Scholar
• Harada D, Yamanaka Y, Ueda K, Nishimura R, Morishima T, Seino Y, etal. Sustained phosphorylation of mutated FGFR3 is a crucial feature of genetic dwarfism and induces apoptosis in the ATDC5 chondrogenic cell line via PLC gamma-activated STATI. Bone. 2007; 41: 273–81.
   Web of Science ®Google Scholar
• Im HJ, Li X, Chen D, Yan D, Kim J, Ellman MB, etal. Biological effects of the plant-derived polyphenol resveratrol in human articular cartilage and chondrosarcoma cells. J Cell Physiol. 2012; 227: 3488–97.
   Web of Science ®Google Scholar
• Kim SJ, Kim HG, Oh CD, Hwang SG, Song WK, Yoo YJ, etal. p38 kinase-dependent and -independent Inhibition of protein kinase C zeta and -alpha regulates nitric oxide-induced apoptosis and dedifferentiation of articular chondrocytes. J Biol Chem. 2002; 277: 30375–81.
   Web of Science ®Google Scholar
• Lee WK, Chung KW, Kim GH, Kim SJ. Gallotannin causes differentiation and inflammation via ERK1/2 and p38 kinase pathways in rabbit articular chondrocytes. Mol Med Rep. 2013; 7: 701–7.
   PubMed Web of Science ®Google Scholar
• Potapovich AI, Lulli D, Fidanza P, Kostyuk VA, De Luca C, Pastore S, etal. Plant polyphenols differentially modulate inflammatory responses of human keratinocytes by interfering with activation of transcription factors NFkappaB and AhR and EGFR-ERK pathway. Toxicol Appl Pharmacol. 2011; 255: 138–49.
   PubMed Web of Science ®Google Scholar
• Sahni M, Ambrosetti DC, Mansukhani A, Gertner R, Levy D, Basilico C. FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev. 1999; 13: 1361–6.
   PubMed Web of Science ®Google Scholar
• Sahni M, Raz R, Coffin JD, Levy D, Basilico C. STAT1 mediates the increased apoptosis and reduced chondrocyte proliferation in mice overexpressing FGF2. Development. 2001; 128: 2119–29.
   Web of Science ®Google Scholar
• Tian C, Ye X, Zhang R, Long J, Ren W, Ding S, etal. Green tea polyphenols reduced fat deposits in high fat-fed rats via erk1/2-PPARgamma-adiponectin pathway. PLoS One. 2013; 8: e53796.
   PubMed Web of Science ®Google Scholar
• Krejci P, Masri B, Fontaine V, Mekikian PB, Weis M, Prats H, etal. Interaction of fibroblast growth factor and C-natriuretic peptide signaling in regulation of chondrocyte proliferation and extracellular matrix homeostasis. J Cell Sci. 2005; 118: 5089–100.
   PubMed Web of Science ®Google Scholar
• Yasoda A, Komatsu Y, Chusho H, Miyazawa T, Ozasa A, Miura M, etal. Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nat Med. 2004; 10: 80–6.
   PubMed Web of Science ®Google Scholar
• Beenken A, Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov. 2009; 8: 235–53.
   PubMed Web of Science ®Google Scholar
• Blunt AG, Lawshe A, Cunningham ML, Seto ML, Ornitz DM, MacArthur CA. Overlapping expression and redundant activation of mesenchymal fibroblast growth factor (FGF) receptors by alternatively spliced FGF-8 ligands. J Biol Chem. 1997; 272: 3733–8.
   PubMed Web of Science ®Google Scholar
• Valverde-Franco G, Binette JS, Li W, Wang H, Chai S, Laflamme F, etal. Defects in articular cartilage metabolism and early arthritis in fibroblast growth factor receptor 3 deficient mice. Hum Mol Genet. 2006; 15: 1783–92.
   PubMed Web of Science ®Google Scholar
• Ellman MB, Yan D, Ahmadinia K, Chen D, An HS, Im HJ. Fibroblast growth factor control of cartilage homeostasis. J Cell Biochem. 2013; 114: 735–42.
   PubMed Web of Science ®Google Scholar
• Otani Y, Komura M, Komura H, Ishimaru T, Konishi K, Komuro H, etal. Optimal amount of basic fibroblast growth factor in gelatin sponges incorporating beta-tricalcium phosphate with chondrocytes. Tissue Eng Part A. 2015; 21: 627–36.
   Web of Science ®Google Scholar
• Krejci P, Bryja V, Pachernik J, Hampl A, Pogue R, Mekikian P, etal. FGF2 inhibits proliferation and alters the cartilage-like phenotype of RCS cells. Exp Cell Res. 2004; 297: 152–64.
   PubMed Web of Science ®Google Scholar
• L'Hote CGM, Knowles MA. Cell responses to FGFR3 signalling: growth, differentiation and apoptosis. Exp Cell Res. 2005; 304: 417–31.
   PubMed Web of Science ®Google Scholar
• Joven J, March I, Espinel E, Fernandez-Arroyo S, Rodriguez-Gallego E, Aragones G, etal. Hibiscus sabdariffa extract lowers blood pressure and improves endothelial function. Mol Nutr Food Res. 2014; 58: 1374–8.
   PubMed Web of Science ®Google Scholar
• Yamashita A, Morioka M, Kishi H, Kimura T, Yahara Y, Okada M, etal. Statin treatment rescues FGFR3 skeletal dysplasia phenotypes. Nature. 2014; 513: 507–11.
   PubMed Web of Science ®Google Scholar
• Yudoh K, Karasawa R. Statin prevents chondrocyte aging and degeneration of articular cartilage in osteoarthritis (OA). Aging. 2010; 2: 990–8.
   Google Scholar
• Masana L, Camprubi M, Sarda P, Sola R, Joven J, Turner PR. The Mediterranean-type diet: is there a need for further modification?. Am J Clin Nutr. 1991; 53: 886–9.
   PubMed Web of Science ®Google Scholar